Furthermore, our results indicate that the METTL3/miR-146a-5p mediated oncogenic effect in OSCC is via direct targeting of SMAD4, a well-known tumor-suppressor gene, by miR-146a-5p. The gene discussed is METTL3; the disease is neoplasm.